Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-10-31 Purchase |
2022-11-02 6:42 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director |
3,625 | $86.75 | $314,469 | 10,905 (Direct) |
View |
2022-08-17 Sale |
2022-08-17 4:32 pm |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
2,000 | $76 | $152,000 | 0 (Direct) |
View |
2021-06-21 Purchase |
2021-06-21 9:14 pm |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
2,000 | $81.34 | $162,680 | 2,000 (Direct) |
View |
2020-05-13 Purchase |
2020-05-13 5:05 pm |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
10,000 | $8.859 | $88,590 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-09-16 Exercise |
2023-09-19 4:47 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
2,666 | $0 | 9,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-02 4:22 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
10,000 | $0 | 10,000 (Direct) |
View |
2023-05-23 Option Award |
2023-05-24 6:23 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director |
4,190 | $0 | 15,095 (Direct) |
View |
2022-09-16 Option Award |
2022-09-19 5:08 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-06-01 Option Award |
2022-06-02 7:06 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
17,500 | $0 | 17,500 (Direct) |
View |
2022-05-24 Option Award |
2022-05-26 8:12 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director |
4,980 | $0 | 7,280 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 6:09 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director |
2,300 | $0 | 2,300 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:24 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
17,500 | $0 | 17,500 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 5:34 pm |
N/A 2031-06-01 |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
209 | $0 | 209 (Direct) |
View |
2021-05-24 Option Award |
2021-05-26 4:50 pm |
N/A 2031-05-23 |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
17,000 | $0 | 17,000 (Direct) |
View |
2020-06-11 Option Award |
2020-06-11 4:51 pm |
N/A 2030-06-10 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
17,500 | $0 | 17,500 (Direct) |
View |